PROBeX: Exit from Study SOP (1291)
PROBeX SOPTB/Coinfection Studies PROBeX HIVFollow-upManagement StudyTesting DrugExclusionWithdrawal ARTTreatment AfricaTuberculosisPatientDiagnosis XDRResistanceBedaquilineGeneticMechanismsInteractionsPharmakineticSynthesisMedicationsRitonavirLopinavir Exit Death LostDecisionTerminationVoluntarilyAbsenceInternational 2020Community HealthImmunologyVirologyGeneticsClinicalProspective Cohort StudyQuantitativeClinical
PROBeX exit from study SOP.
